AU2015286462B2 - Cardiac cell culture material - Google Patents

Cardiac cell culture material Download PDF

Info

Publication number
AU2015286462B2
AU2015286462B2 AU2015286462A AU2015286462A AU2015286462B2 AU 2015286462 B2 AU2015286462 B2 AU 2015286462B2 AU 2015286462 A AU2015286462 A AU 2015286462A AU 2015286462 A AU2015286462 A AU 2015286462A AU 2015286462 B2 AU2015286462 B2 AU 2015286462B2
Authority
AU
Australia
Prior art keywords
cardiac
cell
vcam
cells
fibroblasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015286462A
Other languages
English (en)
Other versions
AU2015286462A1 (en
Inventor
Takahiro IWAMIYA
Katsuhisa Matsuura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lymphogenix Ltd
Original Assignee
Lymphogenix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lymphogenix Ltd filed Critical Lymphogenix Ltd
Publication of AU2015286462A1 publication Critical patent/AU2015286462A1/en
Application granted granted Critical
Publication of AU2015286462B2 publication Critical patent/AU2015286462B2/en
Assigned to LYMPHOGENIX LIMITED reassignment LYMPHOGENIX LIMITED Request for Assignment Assignors: METCELA INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3826—Muscle cells, e.g. smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1329—Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2015286462A 2014-07-11 2015-01-05 Cardiac cell culture material Active AU2015286462B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014142804 2014-07-11
JP2014-142804 2014-07-11
PCT/JP2015/050028 WO2016006262A1 (ja) 2014-07-11 2015-01-05 心臓細胞培養材料

Publications (2)

Publication Number Publication Date
AU2015286462A1 AU2015286462A1 (en) 2017-03-02
AU2015286462B2 true AU2015286462B2 (en) 2021-04-15

Family

ID=55063910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015286462A Active AU2015286462B2 (en) 2014-07-11 2015-01-05 Cardiac cell culture material

Country Status (8)

Country Link
US (2) US20170112880A1 (enExample)
EP (1) EP3168297B1 (enExample)
JP (2) JP6241893B2 (enExample)
KR (1) KR102263824B1 (enExample)
CN (2) CN111876371A (enExample)
AU (1) AU2015286462B2 (enExample)
CA (1) CA2954743C (enExample)
WO (1) WO2016006262A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6618066B2 (ja) * 2017-02-24 2019-12-11 株式会社メトセラ 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法
CA3110831A1 (en) * 2018-08-29 2020-03-05 Metcela Inc. Method for producing fibroblast, and g-csf-positive fibroblast mass
KR102200341B1 (ko) * 2018-12-21 2021-01-08 고려대학교 산학협력단 지방줄기세포 시트를 함유하는 심장조직 모사 심장이식용 시트 및 이의 제조방법
WO2020203850A1 (ja) 2019-03-29 2020-10-08 国立大学法人長崎大学 培養組織及びその製造方法
CN113498434A (zh) * 2020-01-22 2021-10-12 京东方科技集团股份有限公司 间充质干细胞膜片及其用途
IL296125A (en) 2020-03-04 2022-11-01 Metcela Inc Fibroblasts have an increased ability to produce erythropoietin
KR102283340B1 (ko) * 2020-03-27 2021-07-30 서울대학교산학협력단 심근 직분화를 위한 심장 모사 세포 배양장치 및 이를 이용한 세포 분화 방법
TW202434721A (zh) 2023-02-14 2024-09-01 國立大學法人山口大學 細胞群、三維細胞培養體、醫藥組成物、胞泌體及製作此細胞群的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060193840A1 (en) * 2003-03-28 2006-08-31 Stan Gronthos Perivascular mesenchymal precursor cell induced blood vessel formation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159580A0 (en) * 2001-07-12 2004-06-01 Geron Corp Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
CA2530421C (en) * 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
US9074190B2 (en) * 2003-10-07 2015-07-07 Biomaster, Inc. Cell differentiation of adipose-derived precursor cells
JPWO2006078034A1 (ja) * 2005-01-24 2008-06-19 財団法人ヒューマンサイエンス振興財団 心筋細胞への分化能を有する細胞
BRPI0815416A2 (pt) * 2007-08-15 2014-10-21 Amunix Inc Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
US9051550B2 (en) * 2009-04-09 2015-06-09 Arizona Board Of Regents, On Behalf Of The University Of Arizona Cellular seeding and co-culture of a three dimensional fibroblast construct
US20120045487A1 (en) * 2009-04-29 2012-02-23 The Regents Of The University Of Michigan Multiphasic microfibers for spatially guided cell growth
US8323972B2 (en) * 2009-09-30 2012-12-04 Advanced Technologies And Regenerative Medicine, Llc Mammary artery derived cells and methods of use in tissue repair and regeneration
WO2012162741A1 (en) * 2011-06-01 2012-12-06 Monash University Enrichment of cardiomyocytes
US10017739B2 (en) * 2012-09-06 2018-07-10 Duke University Methods of expanding and assessing B cells and using expanded B cells to treat disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060193840A1 (en) * 2003-03-28 2006-08-31 Stan Gronthos Perivascular mesenchymal precursor cell induced blood vessel formation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KATSUHISA MATSUURA; SHINAKO MASUDA; YUJI HARAGUCHI; NORIKO YASUDA; TATSUYA SHIMIZU; NOBUHISA HAGIWARA; PETER W. ZANDSTRA; TERUO OK: "Creation of mouse embryonic stem cell-derived cardiac cell sheets", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, vol. 32, no. 30, 12 May 2011 (2011-05-12), AMSTERDAM, NL, pages 7355 - 7362, XP028261564, ISSN: 0142-9612, DOI: 10.1016/j.biomaterials.2011.05.042 *
RUIZ-VILLALBA, A. et al. , 'Characterization of Epicardial-Derived Cardiac Interstitial Cells: Differentiation and Mobilization of Heart Fibroblast Progenitors', PLoS ONE, 2013, Vol 8(1) e53694. *
THE JOURNAL OF CLINICAL INVESTIGATION AUG 2009, (2009-08), vol. 119, no. 8, ISSN 1558-8238, pages 2204 - 2217 *

Also Published As

Publication number Publication date
AU2015286462A1 (en) 2017-03-02
EP3168297B1 (en) 2020-09-16
CN111876371A (zh) 2020-11-03
US11801267B2 (en) 2023-10-31
KR20170023188A (ko) 2017-03-02
JP2018029611A (ja) 2018-03-01
WO2016006262A1 (ja) 2016-01-14
EP3168297A4 (en) 2018-03-07
CN106661552A (zh) 2017-05-10
CN106661552B (zh) 2020-07-07
US20170112880A1 (en) 2017-04-27
EP3168297A1 (en) 2017-05-17
JP6241893B2 (ja) 2017-12-06
JP2016027797A (ja) 2016-02-25
CA2954743C (en) 2022-03-15
CA2954743A1 (en) 2016-01-14
KR102263824B1 (ko) 2021-06-10
US20180369288A1 (en) 2018-12-27

Similar Documents

Publication Publication Date Title
AU2015286462B2 (en) Cardiac cell culture material
JP2010500878A (ja) ポリマー膜を用いた幹細胞とフィーダー細胞の共培養方法
CN110234755B (zh) 多能干细胞的分化调控方法
Iwamiya et al. Cardiac fibroblast-derived VCAM-1 enhances cardiomyocyte proliferation for fabrication of bioengineered cardiac tissue
EP3346002B1 (en) Method for reducing pluripotent stem cells, method for producing cell population having reduced pluripotent stem cells
Shimada et al. Efficient expansion of mouse primary tenocytes using a novel collagen gel culture method
Mattioli et al. Stemness characteristics and osteogenic potential of sheep amniotic epithelial cells
TW201504435A (zh) 毛囊形成用組合物之品質管理方法
JP7198524B2 (ja) スフェロイドの製造方法および多能性幹細胞マーカーを発現させる方法
KR101760239B1 (ko) 세포배양 삽입체를 이용한 인간 배아줄기세포 유래 중간엽 세포의 분리방법
JP2021507714A (ja) ヒト真皮線維芽細胞の単離方法
KR20240153589A (ko) 증폭 모낭 간엽계 세포의 제조 방법 및 그 사용
Zhang et al. Sertoli cells promote proliferation of bone marrow-derived mesenchymal stem cells in co-culture
EP4644536A1 (en) Stem cell, preparation method therefor and use thereof, and method for treating bone defect
Sen et al. Very late antigen-5 facilitates stromal progenitor cell differentiation into myofibroblast
WO2019189640A1 (ja) 幹細胞由来涙腺組織の作製方法
KR102896974B1 (ko) 기능성 근위세뇨관 상피세포의 제조 방법
JP6587877B2 (ja) 表皮幹細胞を分離するためのマーカー及び三次元培養表皮の製造方法
EP3569691A1 (en) Method for producing corneal epithelial cell mass
Lorenz et al. Isolation, Culture, and Analyses of Keratinocytes, Fibroblasts, and Hair Follicles from Normal Human Skin and Cancer-Associated Fibroblasts from Skin Tumors
KR20250152812A (ko) 기능성 근위세뇨관 상피세포의 제조 방법
Ergir Pulsing heart at the microscale:: Generation and characterization of human organotypic cardiac microtissues for translational medicine
Iwamiya et al. Regenerative Therapy
Torchio Confined extracellular environment affects pluripotency maintenance and acquisition
JP2006034199A (ja) 心筋前駆細胞の単離方法及び単離用デバイス

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: LYMPHOGENIX LIMITED

Free format text: FORMER OWNER(S): METCELA INC.